1. Home
  2. CRBP vs MED Comparison

CRBP vs MED Comparison

Compare CRBP & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$7.63

Market Cap

134.8M

Sector

Health Care

ML Signal

HOLD

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$10.48

Market Cap

120.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBP
MED
Founded
2009
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
134.8M
120.6M
IPO Year
2014
1996

Fundamental Metrics

Financial Performance
Metric
CRBP
MED
Price
$7.63
$10.48
Analyst Decision
Strong Buy
Hold
Analyst Count
8
1
Target Price
$50.29
$12.00
AVG Volume (30 Days)
138.7K
244.2K
Earning Date
01-01-0001
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
64.31
N/A
EPS
N/A
N/A
Revenue
$4,822,272.00
$934,842,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$220.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
97.62
N/A
52 Week Low
$4.64
$10.10
52 Week High
$20.56
$15.37

Technical Indicators

Market Signals
Indicator
CRBP
MED
Relative Strength Index (RSI) 43.45 39.17
Support Level $6.73 $10.23
Resistance Level $8.43 $12.21
Average True Range (ATR) 0.47 0.42
MACD 0.00 -0.05
Stochastic Oscillator 38.50 34.44

Price Performance

Historical Comparison
CRBP
MED

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Share on Social Networks: